Information Provided By: 
Fly News Breaks for November 18, 2015
AZN, ZSPH
Nov 18, 2015 | 07:26 EDT
Citi analyst Yigal Nochomovitz downgraded ZS Pharma (ZSPH) to Neutral on AstraZeneca's (AZN) $90 per share takeover agreement.
News For ZSPH;AZN From the Last 2 Days
AZN
Apr 23, 2024 | 11:16 EDT
Bearish flow noted in AstraZeneca with 3,362 puts trading, or 1.7x expected. Most active are 4/26 weekly 70 puts and May-24 70 calls, with total volume in those strikes near 3,600 contracts. The Put/Call Ratio is 1.72, while ATM IV is up nearly 2 points on the day. Earnings are expected on April 25th.
